Home Table of Contents

§ 21-2A-02. Prescription Drug Monitoring Program

West's Annotated Code of MarylandHealth--GeneralEffective: October 1, 2022

West's Annotated Code of Maryland
Health--General
Title 21. Food, Drugs, and Cosmetics (Refs & Annos)
Subtitle 2a. Prescription Drug Monitoring Program (Refs & Annos)
Effective: October 1, 2022
MD Code, Health - General, § 21-2A-02
§ 21-2A-02. Prescription Drug Monitoring Program
Currentness
In general
(a) There is a Prescription Drug Monitoring Program in the Department.
Mission of Program
(b) The mission of the Program is to:
(1) Assist prescribers, pharmacists, and public health professionals in:
(i) The identification and prevention of prescription drug abuse; and
(ii) The identification and investigation of unlawful prescription drug diversion; and
(2) Promote a balanced use of prescription monitoring data to assist appropriate law enforcement activities while preserving the professional practice of health care providers and the access of patients to optimal pharmaceutical care.
Substances and medications to be monitored
(c) To carry out its mission, the Program shall monitor the prescribing and dispensing of all Schedule II, Schedule III, Schedule IV, and Schedule V controlled dangerous substances and the dispensing of naloxone medication by all prescribers and dispensers in the State.

Credits

Added by Acts 2011, c. 166, § 2, eff. Oct. 1, 2011. Amended by Acts 2014, c. 651, § 1, eff. Oct. 1, 2014; Acts 2016, c. 147, § 2, eff. Oct. 1, 2016; Acts 2019, c. 531, § 1, eff. Oct. 1, 2019; Acts 2022, c. 224, § 1, eff. Oct. 1, 2022.
MD Code, Health - General, § 21-2A-02, MD HEALTH GEN § 21-2A-02
Current through legislation effective through April 9, 2023, from the 2024 Regular Session of the General Assembly. Some statute sections may be more current, see credits for details.
End of Document